Dehydroepiandrosterone, 17α-hydroxyprogesterone and aldosterone responses to the low-dose (1 µg) ACTH test in subjects with preclinical adrenal autoimmunity
- 22 October 2002
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 57 (5) , 677-683
- https://doi.org/10.1046/j.1365-2265.2002.01651.x
Abstract
The appearance of 21-hydroxylase autoantibodies (21OHAbs) identifies subjects with preclinical adrenal insufficiency. In 21OHAb-positive subjects, the adrenocortical function is best evaluated by peak cortisol (F) levels after the low-dose (1 micro g) ACTH stimulation test (LDT). No information is currently available on the correlation between F and other adrenocortical hormone responses to the LDT in subjects with an ongoing autoimmune adrenal process. In this study, we tested the hypothesis that the dehydroepiandrosterone (DHEA), 17alpha-hydroxyprogesterone (17OHP) and aldosterone (A) responses to the LDT are consensual to that of F during the preclinical phase of autoimmune adrenal insufficiency. We studied 12 subjects positive for 21OHAb, in the absence of clinical signs of adrenal insufficiency. On the basis of peak F levels after the LDT, and according to the lower level of normal observed in 15 healthy volunteers (510.4 nmol/l), patients were subdivided into two groups: group A, n = 6 subjects with normal F response; and group B, n = 6 subjects with impaired F response. Results were expressed as absolute delta increase (Delta) between peak and basal levels. DeltaF was significantly higher in group A (314.5 +/- 115.8 nmol/l) than in group B (151.7 +/- 88.2 nmol/l) (P = 0.041). DeltaDHEA and Delta17OHP were also significantly higher in group A (17.0 +/- 13.5 nmol/l and 6.1 +/- 4.4 nmol/l, respectively) than in group B (0.69 +/- 2.25 nmol/l and 1.9 +/- 1.7 nmol/l, respectively) (P = 0.002 and P = 0.041). The difference in DeltaA between the two groups did not reach statistical significance (group A 321.8 +/- 272.0 pmol/l vs. group B 157.0 +/- 154.0 pmol/l). DeltaDHEA, Delta17OHP and DeltaA tended to correlate positively with DeltaF (P = 0.039, P = 0.039 and P = 0.044, respectively), but the correlations did not reach significance after correction of the P-value. Our study demonstrates a high concordance between F and DHEA, 17OHP and A responses to the LDT in subjects with preclinical adrenal autoimmunity, thus strengthening the concept that the LDT is an accurate test to identify early adrenal dysfunction.Keywords
This publication has 19 references indexed in Scilit:
- Low dose (1 μg) ACTH test in the evaluation of adrenal dysfunction in pre‐clinical Addison's diseaseClinical Endocrinology, 2000
- Adrenal Autoimmunity and Correlation with Adrenal DysfunctionThe Endocrinologist, 2000
- The role of the low dose ACTH test in the evaluation of central hypoadrenalismJournal of Endocrinological Investigation, 1999
- Clinical usefulness of the low dose ACTH testJournal of Endocrinological Investigation, 1999
- The low dose (1 μg) ACTH test ‐ when and how to use it.Clinical Endocrinology, 1998
- Comparison of Low and High Dose Corticotropin Stimulation Tests in Patients with Pituitary DiseaseJournal of Clinical Endocrinology & Metabolism, 1998
- 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's diseaseClinical and Experimental Immunology, 1997
- Low-Dose ACTH Stimulation TestThe Endocrinologist, 1997
- Dose–response aspects in the clinical assessment of the hypothalamo-pituitary-adrenal axis, and the low-dose adrenocorticotropin testActa Endocrinologica, 1996
- Responses of plasma adrenocortical steroids to low dose ACTH in normal subjectsClinical Endocrinology, 1995